SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Xenova (XNVA) -- Ignore unavailable to you. Want to Upgrade?


To: Extra Pale who wrote (135)8/4/2005 7:06:37 PM
From: nigel bates  Respond to of 173
 
congrats to celtic for what may be a great vulture buy. however, from a stockholder viewpoint this deal sucks... (lots of sour grapes & losses...)

Lots of dittos.



To: Extra Pale who wrote (135)8/4/2005 8:01:18 PM
From: Robohogs  Read Replies (1) | Respond to of 173
 
I know - really awful deal. They probably structured like this so they could get premium way down unless one took the toxic notes. Ugly! The notes are secured on the sub-licenses to Celtic. Equity risk in notes form with illiquidity to boot.

Jon